These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT. Griffin SJ; Bethel MA; Holman RR; Khunti K; Wareham N; Brierley G; Davies M; Dymond A; Eichenberger R; Evans P; Gray A; Greaves C; Harrington K; Hitman G; Irving G; Lessels S; Millward A; Petrie JR; Rutter M; Sampson M; Sattar N; Sharp S Health Technol Assess; 2018 Apr; 22(18):1-64. PubMed ID: 29652246 [TBL] [Abstract][Full Text] [Related]
6. Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial. Løvvik TS; Carlsen SM; Salvesen Ø; Steffensen B; Bixo M; Gómez-Real F; Lønnebotn M; Hestvold KV; Zabielska R; Hirschberg AL; Trouva A; Thorarinsdottir S; Hjelle S; Berg AH; Andræ F; Poromaa IS; Mohlin J; Underdal M; Vanky E Lancet Diabetes Endocrinol; 2019 Apr; 7(4):256-266. PubMed ID: 30792154 [TBL] [Abstract][Full Text] [Related]
7. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial. Feig DS; Donovan LE; Zinman B; Sanchez JJ; Asztalos E; Ryan EA; Fantus IG; Hutton E; Armson AB; Lipscombe LL; Simmons D; Barrett JFR; Karanicolas PJ; Tobin S; McIntyre HD; Tian SY; Tomlinson G; Murphy KE; Lancet Diabetes Endocrinol; 2020 Oct; 8(10):834-844. PubMed ID: 32946820 [TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
9. Manchester Intermittent Diet in Gestational Diabetes Acceptability Study (MIDDAS-GDM): a two-arm randomised feasibility protocol trial of an intermittent low-energy diet (ILED) in women with gestational diabetes and obesity in Greater Manchester. Dapre E; Issa BG; Harvie M; Su TL; McMillan B; Pilkington A; Hanna F; Vyas A; Mackie S; Yates J; Evans B; Mubita W; Lombardelli C BMJ Open; 2024 Feb; 14(2):e078264. PubMed ID: 38341207 [TBL] [Abstract][Full Text] [Related]
10. Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes. Dodd JM; Grivell RM; Deussen AR; Hague WM Cochrane Database Syst Rev; 2018 Jul; 7(7):CD010564. PubMed ID: 30039871 [TBL] [Abstract][Full Text] [Related]
12. The effects of metformin on weight loss in women with gestational diabetes: a pilot randomized, placebo-controlled trial. Refuerzo JS; Viteri OA; Hutchinson M; Pedroza C; Blackwell SC; Tyson JE; Ramin SM Am J Obstet Gynecol; 2015 Mar; 212(3):389.e1-9. PubMed ID: 25526875 [TBL] [Abstract][Full Text] [Related]
13. Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the GRoW randomised, double-blind, placebo-controlled trial. Dodd JM; Louise J; Deussen AR; Grivell RM; Dekker G; McPhee AJ; Hague W Lancet Diabetes Endocrinol; 2019 Jan; 7(1):15-24. PubMed ID: 30528218 [TBL] [Abstract][Full Text] [Related]
14. Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial. Matthews DR; Paldánius PM; Proot P; Chiang Y; Stumvoll M; Del Prato S; Lancet; 2019 Oct; 394(10208):1519-1529. PubMed ID: 31542292 [TBL] [Abstract][Full Text] [Related]
15. A randomised placebo-controlled trial of the effectiveness of early metformin in addition to usual care in the reduction of gestational diabetes mellitus effects (EMERGE): study protocol. Dunne F; Newman C; Devane D; Smyth A; Alvarez-Iglesias A; Gillespie P; Browne M; O'Donnell M Trials; 2022 Sep; 23(1):795. PubMed ID: 36131291 [TBL] [Abstract][Full Text] [Related]
16. Practice nurse-supported weight self-management delivered within the national child immunisation programme for postnatal women: a feasibility cluster RCT. Daley AJ; Jolly K; Ives N; Jebb SA; Tearne S; Greenfield SM; Yardley L; Little P; Tyldesley-Marshall N; Bensoussane H; Pritchett RV; Frew E; Parretti HM Health Technol Assess; 2021 Aug; 25(49):1-130. PubMed ID: 34382932 [TBL] [Abstract][Full Text] [Related]
17. Carer administration of as-needed subcutaneous medication for breakthrough symptoms in people dying at home: the CARiAD feasibility RCT. Poolman M; Roberts J; Wright S; Hendry A; Goulden N; Holmes EA; Byrne A; Perkins P; Hoare Z; Nelson A; Hiscock J; Hughes D; O'Connor J; Foster B; Reymond L; Healy S; Lewis P; Wee B; Johnstone R; Roberts R; Parkinson A; Roberts S; Wilkinson C Health Technol Assess; 2020 May; 24(25):1-150. PubMed ID: 32484432 [TBL] [Abstract][Full Text] [Related]
18. Pregnancy Outcomes: Effects of Metformin (POEM) study: a protocol for a long-term, multicentre, open-label, randomised controlled trial in gestational diabetes mellitus. van Hoorn EGM; van Dijk PR; Prins JR; Lutgers HL; Hoogenberg K; Erwich JJHM; Kooy A BMJ Open; 2022 Mar; 12(3):e056282. PubMed ID: 35354633 [TBL] [Abstract][Full Text] [Related]
19. Oral anti-diabetic pharmacological therapies for the treatment of women with gestational diabetes. Brown J; Martis R; Hughes B; Rowan J; Crowther CA Cochrane Database Syst Rev; 2017 Jan; 1(1):CD011967. PubMed ID: 28120427 [TBL] [Abstract][Full Text] [Related]
20. Chinese women's attitudes towards postpartum interventions to prevent type 2 diabetes after gestational diabetes: a semi-structured qualitative study. Shang J; Henry A; Zhang P; Chen H; Thompson K; Wang X; Liu N; Zhang J; Liu Y; Jin J; Pan X; Yang X; Hirst JE Reprod Health; 2021 Jun; 18(1):133. PubMed ID: 34174913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]